세포 분석 시장 규모, 점유율, 동향 분석 보고서 : 제품 및 서비스별, 기술별, 공정별, 용도별, 지역별, 부문별 예측(2026-2033년)

Cell Analysis Market Summary

The global cell analysis market size was estimated at USD 34.3 billion in 2025 and is projected to reach USD 81.0 billion by 2033, growing at a CAGR of 11.7% from 2026 to 2033. Market growth is driven by the rising prevalence of chronic diseases, advancements in cell analysis technologies, and increasing drug discovery activities.

The application of cell analysis has expanded from early-stage cancer diagnostics to the development of cancer-targeted therapies and tools, strengthening its role in oncology.

Companies are actively investing in advanced cell analysis methods to support the development of innovative treatments. For instance, in March 2024, Serum Detect announced the launch of a T-cell analysis approach for early cancer detection at the American Association for Cancer Research (AACR). Such initiatives are expected to support market growth during the forecast period.

Global Cell Analysis Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global cell analysis market report based on the product & service, technique, process, end-use, and region.

• Product & Service Outlook (Revenue, USD Million, 2021 - 2033)
• Reagents & Consumables
• Instruments
• Accessories
• Software
• Service
• Technique Outlook (Revenue, USD Million, 2021 - 2033)
• Flow Cytometry
• PCR
• Cell Microarrays
• Microscopy
• Spectrophotometry
• High Content-Screening
• Other Techniques
• Process Outlook (Revenue, USD Million, 2021 - 2033)
• Cell Identification
• Cell Viability
• Cell Signaling Pathways
• Cell Proliferation
• Cell Counting
• Cell Interaction
• Cell Structure Study
• Single-cell Analysis
• Others
• End-use Outlook (Revenue, USD Million, 2021 - 2033)
• Pharmaceutical & Biotechnology Companies
• Hospitals & Clinical Testing Laboratories
• Academic & Research Institutes
• Other
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
  • 1.2.1. Product & Service Segment
  • 1.2.2. Technique Segment
  • 1.2.3. Process Segment
  • 1.2.4. End-use Segment
• 1.3. Information analysis
  • 1.3.1. Market formulation & data visualization
• 1.4. Data validation & publishing
• 1.5. Information Procurement
  • 1.5.1. Primary Research
• 1.6. Information or Data Analysis
• 1.7. Market Formulation & Validation
• 1.8. Market Model
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Cell Analysis Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing prevalence of chronic diseases
    • 3.2.1.2. Advancements in cell analysis technologies
    • 3.2.1.3. Growing number of drug discovery activities
    • 3.2.1.4. Rising demand for personalized and precision medicine
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Complexity of cell analysis techniques
    • 3.2.2.2. High cost of instruments and reagents
    • 3.2.2.3. Standardization and reproducibility challenges
  • 3.2.3. Market opportunity analysis
  • 3.2.4. Market challenge analysis
• 3.3. Cell Analysis Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis

Chapter 4. Cell Analysis Market: Product & Service Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Cell Analysis Market Product & Service Movement Analysis
• 4.3. Global Cell Analysis Materials Market Size & Trend Analysis, by Product & Service, 2021 to 2033 (USD Million)
• 4.4. Reagents & Consumables
  • 4.4.1. Reagents & Consumables market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.5. Instruments
  • 4.5.1. Instruments market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.6. Accessories
  • 4.6.1. Accessories market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.7. Software
  • 4.7.1. Software market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.8. Service
  • 4.8.1. Service market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 5. Cell Analysis Market: Technique Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Cell Analysis Market Technique Movement Analysis
• 5.3. Global Cell Analysis Materials Market Size & Trend Analysis, by Technique, 2021 to 2033 (USD Million)
• 5.4. Flow Cytometry
  • 5.4.1. Flow Cytometry market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.5. PCR
  • 5.5.1. PCR market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.6. Cell Microarrays
  • 5.6.1. Cell Microarrays market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.7. Microscopy
  • 5.7.1. Microscopy market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.8. Spectrophotometry
  • 5.8.1. Spectrophotometry market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.9. High Content-Screening
  • 5.9.1. High Content-Screening market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.10. Other Techniques
  • 5.10.1. Other Techniques market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 6. Cell Analysis Materials Market: Process Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Cellular Starting Materials Market Process Movement Analysis
• 6.3. Global Cellular Starting Materials Market Size & Trend Analysis, by Process, 2021 to 2033 (USD Million)
• 6.4. Cell Identification
  • 6.4.1. Cell Identification market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.5. Cell Viability
  • 6.5.1. Cell Viability market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.6. Cell Signaling Pathways
  • 6.6.1. Cell Signaling Pathways market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.7. Cell Proliferation
  • 6.7.1. Cell Proliferation market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.8. Cell Counting
  • 6.8.1. Cell Counting market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.9. Cell Interaction
  • 6.9.1. Cell Interaction market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.10. Cell Structure Study
  • 6.10.1. Cell Structure Study market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.11. Single-cell Analysis
  • 6.11.1. Single-cell Analysis market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.12. Others
  • 6.12.1. Others market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 7. Cellular Starting Materials Market: End-use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global Cellular Starting Materials Market End-use Movement Analysis
• 7.3. Global Cellular Starting Materials Market Size & Trend Analysis, by End-use, 2021 to 2033 (USD Million)
• 7.4. Pharmaceutical & Biotechnology Companies
  • 7.4.1. Pharmaceutical & Biotechnology Companies market estimates and forecasts, 2021 to 2033 (USD Million)
• 7.5. Hospitals & Clinical Testing Laboratories
  • 7.5.1. Hospitals & Clinical Testing Laboratories market estimates and forecasts, 2021 to 2033 (USD Million)
• 7.6. Academic & Research Institutes
  • 7.6.1. Academic & Research Institutes market estimates and forecasts, 2021 to 2033 (USD Million)
• 7.7. Other
  • 7.7.1. Other market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 8. Cell Analysis Market: Regional Estimates & Trend Analysis

• 8.1. Regional Market Share Analysis, 2025 & 2033
• 8.2. Regional Market Dashboard
• 8.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
• 8.4. North America
  • 8.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.4.2. U.S.
    • 8.4.2.1. Key country dynamics
    • 8.4.2.2. Competitive scenario
    • 8.4.2.3. Regulatory framework
    • 8.4.2.4. U.S. market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.4.3. Canada
    • 8.4.3.1. Key country dynamics
    • 8.4.3.2. Competitive scenario
    • 8.4.3.3. Regulatory framework
    • 8.4.3.4. Canada market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.4.4. Mexico
    • 8.4.4.1. Key country dynamics
    • 8.4.4.2. Competitive scenario
    • 8.4.4.3. Regulatory framework
    • 8.4.4.4. Mexico market estimates and forecasts, 2021 to 2033 (USD Million)
• 8.5. Europe
  • 8.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.5.2. UK
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Competitive scenario
    • 8.5.2.3. Regulatory framework
    • 8.5.2.4. UK market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.5.3. Germany
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Competitive scenario
    • 8.5.3.3. Regulatory framework
    • 8.5.3.4. Germany market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.5.4. France
    • 8.5.4.1. Key country dynamics
    • 8.5.4.2. Competitive scenario
    • 8.5.4.3. Regulatory framework
    • 8.5.4.4. France market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.5.5. Italy
    • 8.5.5.1. Key country dynamics
    • 8.5.5.2. Competitive scenario
    • 8.5.5.3. Regulatory framework
    • 8.5.5.4. Italy market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.5.6. Spain
    • 8.5.6.1. Key country dynamics
    • 8.5.6.2. Competitive scenario
    • 8.5.6.3. Regulatory framework
    • 8.5.6.4. Spain market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.5.7. Norway
    • 8.5.7.1. Key country dynamics
    • 8.5.7.2. Competitive scenario
    • 8.5.7.3. Regulatory framework
    • 8.5.7.4. Norway market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.5.8. Sweden
    • 8.5.8.1. Key country dynamics
    • 8.5.8.2. Competitive scenario
    • 8.5.8.3. Regulatory framework
    • 8.5.8.4. Sweden market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.5.9. Denmark
    • 8.5.9.1. Key country dynamics
    • 8.5.9.2. Competitive scenario
    • 8.5.9.3. Regulatory framework
    • 8.5.9.4. Denmark market estimates and forecasts, 2021 to 2033 (USD Million)
• 8.6. Asia Pacific
  • 8.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.6.2. Japan
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Competitive scenario
    • 8.6.2.3. Regulatory framework
    • 8.6.2.4. Japan market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.6.3. China
    • 8.6.3.1. Key country dynamics
    • 8.6.3.2. Competitive scenario
    • 8.6.3.3. Regulatory framework
    • 8.6.3.4. China market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.6.4. India
    • 8.6.4.1. Key country dynamics
    • 8.6.4.2. Competitive scenario
    • 8.6.4.3. Regulatory framework
    • 8.6.4.4. India market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.6.5. Australia
    • 8.6.5.1. Key country dynamics
    • 8.6.5.2. Competitive scenario
    • 8.6.5.3. Regulatory framework
    • 8.6.5.4. Australia market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.6.6. South Korea
    • 8.6.6.1. Key country dynamics
    • 8.6.6.2. Competitive scenario
    • 8.6.6.3. Regulatory framework
    • 8.6.6.4. South Korea market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.6.7. Thailand
    • 8.6.7.1. Key country dynamics
    • 8.6.7.2. Competitive scenario
    • 8.6.7.3. Regulatory framework
    • 8.6.7.4. Thailand market estimates and forecasts, 2021 to 2033 (USD Million)
• 8.7. Latin America
  • 8.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.7.2. Brazil
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Competitive scenario
    • 8.7.2.3. Regulatory framework
    • 8.7.2.4. Brazil market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.7.3. Argentina
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Competitive scenario
    • 8.7.3.3. Regulatory framework
    • 8.7.3.4. Argentina market estimates and forecasts, 2021 to 2033 (USD Million)
• 8.8. MEA
  • 8.8.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.8.2. South Africa
    • 8.8.2.1. Key country dynamics
    • 8.8.2.2. Competitive scenario
    • 8.8.2.3. Regulatory framework
    • 8.8.2.4. South Africa market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.8.3. Saudi Arabia
    • 8.8.3.1. Key country dynamics
    • 8.8.3.2. Competitive scenario
    • 8.8.3.3. Regulatory framework
    • 8.8.3.4. Saudi Arabia market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.8.4. UAE
    • 8.8.4.1. Key country dynamics
    • 8.8.4.2. Competitive scenario
    • 8.8.4.3. Regulatory framework
    • 8.8.4.4. UAE market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.8.5. Kuwait
    • 8.8.5.1. Key country dynamics
    • 8.8.5.2. Competitive scenario
    • 8.8.5.3. Regulatory framework
    • 8.8.5.4. Kuwait market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Company/Competition Categorization
• 9.2. Strategy Mapping
• 9.3. Company Market Position Analysis, 2025
• 9.4. Company Profiles/Listing
  • 9.4.1. Thermo Fisher Scientific, Inc.
    • 9.4.1.1. Company overview
    • 9.4.1.2. Financial performance
    • 9.4.1.3. Product benchmarking
    • 9.4.1.4. Strategic initiatives
  • 9.4.2. Danaher
    • 9.4.2.1. Company overview
    • 9.4.2.2. Financial performance
    • 9.4.2.3. Product benchmarking
    • 9.4.2.4. Strategic initiatives
  • 9.4.3. BD
    • 9.4.3.1. Company overview
    • 9.4.3.2. Financial performance
    • 9.4.3.3. Product benchmarking
    • 9.4.3.4. Strategic initiatives
  • 9.4.4. Merck KGaA
    • 9.4.4.1. Company overview
    • 9.4.4.2. Financial performance
    • 9.4.4.3. Product benchmarking
    • 9.4.4.4. Strategic initiatives
  • 9.4.5. Agilent Technologies, Inc.
    • 9.4.5.1. Company overview
    • 9.4.5.2. Financial performance
    • 9.4.5.3. Product benchmarking
    • 9.4.5.4. Strategic initiatives
  • 9.4.6. Bio-Rad Laboratories, Inc.
    • 9.4.6.1. Company overview
    • 9.4.6.2. Financial performance
    • 9.4.6.3. Product benchmarking
    • 9.4.6.4. Strategic initiatives
  • 9.4.7. Miltenyl Biotech
    • 9.4.7.1. Company overview
    • 9.4.7.2. Financial performance
    • 9.4.7.3. Product benchmarking
    • 9.4.7.4. Strategic initiatives
  • 9.4.8. Revvity
    • 9.4.8.1. Company overview
    • 9.4.8.2. Financial performance
    • 9.4.8.3. Product benchmarking
    • 9.4.8.4. Strategic initiatives
  • 9.4.9. New England Biolabs
    • 9.4.9.1. Company overview
    • 9.4.9.2. Financial performance
    • 9.4.9.3. Product benchmarking
    • 9.4.9.4. Strategic initiatives
  • 9.4.10. Avantor, Inc.
    • 9.4.10.1. Company overview
    • 9.4.10.2. Financial performance
    • 9.4.10.3. Product benchmarking
    • 9.4.10.4. Strategic initiatives